{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:05:34Z","timestamp":1779318334118,"version":"3.51.4"},"reference-count":202,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Dieses Positionspapier beinhaltet die Empfehlungen der \u00d6sterreichischen Diabetes Gesellschaft zum Management von Patient*innen mit Diabetes mellitus w\u00e4hrend station\u00e4rer Aufenthalte und im perioperativen Setting, basierend auf aktueller Evidenz zu Glukosezielbereichen, Insulintherapie und Therapie mit oralen\/injizierbaren Antidiabetika. Zus\u00e4tzlich werden Spezialsituationen wie intraven\u00f6se Insulintherapie, begleitende Glukokortikoidtherapie sowie die Anwendung von Diabetestechnologie im station\u00e4ren und perioperativen Bereich diskutiert.<\/jats:p>","DOI":"10.1007\/s00508-026-02717-9","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:14:07Z","timestamp":1779315247000},"page":"308-330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetesmanagement im Krankenhaus (Update 2026)","Hospital diabetes management (Update 2026)"],"prefix":"10.1007","volume":"138","author":[{"given":"Julia K.","family":"Mader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Aberer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna M.","family":"Brix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"F\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Hochfellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia-Therese","family":"Kietaibl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Ludvik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Resl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Ress-Winkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Stechemesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Vonbank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Sourij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Clodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"Supplement_1","key":"2717_CR1","doi-asserted-by":"publisher","first-page":"S295","DOI":"10.2337\/dc24-S016","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2023","unstructured":"American Diabetes Association Professional Practice Committee. Diabetes Care in the Hospital: Standards of Care in Diabetes\u20142024. Diabetes Care. 2023;47(Supplement_1):S295\u2013S306. https:\/\/doi.org\/10.2337\/dc24-S016.","journal-title":"Diabetes Care"},{"key":"2717_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60553-5","author":"D Km","year":"2009","unstructured":"Km\u00a0D, Ss\u00a0B, Jc\u00a0P. Stress hyperglycaemia. Lancet (London, England). 2009; https:\/\/doi.org\/10.1016\/S0140-6736(09)60553-5.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"2717_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0749-0690(18)30059-4","volume":"15","author":"HK Kamel","year":"1999","unstructured":"Kamel\u00a0HK, Rodriguez-Salda\u00f1a\u00a0J, Flaherty\u00a0JH, Miller\u00a0DK. Diabetes mellitus among ethnic seniors: contrasts with diabetes in whites. Clin Geriatr Med. 1999;15(2):265\u201378.","journal-title":"Clin Geriatr Med"},{"issue":"2","key":"2717_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0749-0690(18)30055-7","volume":"15","author":"JE Morley","year":"1999","unstructured":"Morley\u00a0JE. An overview of diabetes mellitus in older persons. Clin Geriatr Med. 1999;15(2):211\u201324.","journal-title":"Clin Geriatr Med"},{"issue":"12","key":"2717_CR5","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1097\/CCM.0000000000001353","volume":"43","author":"DL Carpenter","year":"2015","unstructured":"Carpenter\u00a0DL, Gregg\u00a0SR, Xu\u00a0K, Buchman\u00a0TG, Coopersmith\u00a0CM. Prevalence and Impact of Unknown Diabetes in the ICU. Crit Care Med. 2015;43(12):e541\u2013e50. https:\/\/doi.org\/10.1097\/CCM.0000000000001353.","journal-title":"Crit Care Med"},{"issue":"6","key":"2717_CR6","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4158\/EP11042.OR","volume":"17","author":"CM Swanson","year":"2011","unstructured":"Swanson\u00a0CM, Potter\u00a0DJ, Kongable\u00a0GL, Cook\u00a0CB. Update on inpatient glycemic control in hospitals in the United States. Endocr Pract. 2011;17(6):853\u201361. https:\/\/doi.org\/10.4158\/EP11042.OR.","journal-title":"Endocr Pract"},{"issue":"11","key":"2717_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14113668","volume":"14","author":"MW Heinzl","year":"2025","unstructured":"Heinzl\u00a0MW, Resl\u00a0M, Kellermair\u00a0J, et\u00a0al. Intrahospital Prevalence of Diabetes and Prediabetes in Medical Departments in Upper Austria. J\u00a0Clin Med. 2025;14(11)3668. https:\/\/doi.org\/10.3390\/jcm14113668.","journal-title":"J Clin Med"},{"key":"2717_CR8","volume-title":"StatPearls","author":"P Dogra","year":"2022","unstructured":"Dogra\u00a0P, Jialal\u00a0I. Diabetic Perioperative Management. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022."},{"issue":"8","key":"2717_CR9","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2337\/dc10-0304","volume":"33","author":"A Frisch","year":"2010","unstructured":"Frisch\u00a0A, Chandra\u00a0P, Smiley\u00a0D, et\u00a0al. Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery. Diabetes Care. 2010;33(8):1783\u20138. https:\/\/doi.org\/10.2337\/dc10-0304.","journal-title":"Diabetes Care"},{"issue":"1","key":"2717_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/SLA.0000000000000688","volume":"261","author":"M Kotagal","year":"2015","unstructured":"Kotagal\u00a0M, Symons\u00a0RG, Hirsch\u00a0IB, et\u00a0al. Perioperative Hyperglycemia and Risk of Adverse Events Among Patients With and Without Diabetes. Ann Surg. 2015;261(1):97\u2013103. https:\/\/doi.org\/10.1097\/SLA.0000000000000688.","journal-title":"Ann Surg"},{"issue":"9","key":"2717_CR11","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.2337\/dc15-0303","volume":"38","author":"G Umpierrez","year":"2015","unstructured":"Umpierrez\u00a0G, Cardona\u00a0S, Pasquel\u00a0F, et\u00a0al. Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial. Diabetes Care. 2015;38(9):1665\u201372. https:\/\/doi.org\/10.2337\/dc15-0303.","journal-title":"Diabetes Care"},{"issue":"4","key":"2717_CR12","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/jocs.16278","volume":"37","author":"D Vervoort","year":"2022","unstructured":"Vervoort\u00a0D, Lia\u00a0H, Fremes\u00a0SE. Sweet victory: Optimizing glycemic control after coronary artery bypass grafting. Journal of Cardiac Surgery. 2022;37(4):937\u201340. https:\/\/doi.org\/10.1111\/jocs.16278.","journal-title":"Journal of Cardiac Surgery"},{"issue":"4","key":"2717_CR13","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2337\/diacare.28.4.810","volume":"28","author":"FA McAlister","year":"2005","unstructured":"McAlister\u00a0FA, Majumdar\u00a0SR, Blitz\u00a0S, Rowe\u00a0BH, Romney\u00a0J, Marrie\u00a0TJ. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28(4):810\u20135. https:\/\/doi.org\/10.2337\/diacare.28.4.810.","journal-title":"Diabetes Care"},{"issue":"8","key":"2717_CR14","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2337\/dc10-0304","volume":"33","author":"A Frisch","year":"2010","unstructured":"Frisch\u00a0A, Chandra\u00a0P, Smiley\u00a0D, et\u00a0al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33(8):1783\u20138. https:\/\/doi.org\/10.2337\/dc10-0304.","journal-title":"Diabetes Care"},{"issue":"12","key":"2717_CR15","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.4065\/78.12.1471","volume":"78","author":"JS Krinsley","year":"2003","unstructured":"Krinsley\u00a0JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78(12):1471\u20138. https:\/\/doi.org\/10.4065\/78.12.1471.","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"2717_CR16","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1097\/CCM.0b013e3181b083f7","volume":"37","author":"M Falciglia","year":"2009","unstructured":"Falciglia\u00a0M, Freyberg\u00a0RW, Almenoff\u00a0PL, D\u2019Alessio\u00a0DA, Render\u00a0ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37(12):3001\u20139. https:\/\/doi.org\/10.1097\/CCM.0b013e3181b083f7.","journal-title":"Crit Care Med"},{"issue":"11","key":"2717_CR17","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.2337\/dc08-0672","volume":"31","author":"A Bruno","year":"2008","unstructured":"Bruno\u00a0A, Gregori\u00a0D, Caropreso\u00a0A, Lazzarato\u00a0F, Petrinco\u00a0M, Pagano\u00a0E. Normal Glucose Values Are Associated With a Lower Risk of Mortality in Hospitalized Patients. Diabetes Care. 2008;31(11):2209\u201310. https:\/\/doi.org\/10.2337\/dc08-0672.","journal-title":"Diabetes Care"},{"key":"2717_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101147","author":"IM Carey","year":"2025","unstructured":"Carey\u00a0IM, Critchley\u00a0JA, Chaudhry\u00a0UAR, et\u00a0al. Contribution of infection to mortality in people with type 2 diabetes: a population-based cohort study using electronic records. Lancet Reg Health Eur. 2025; https:\/\/doi.org\/10.1016\/j.lanepe.2024.101147.","journal-title":"The Lancet Regional Health \u2013 Europe"},{"issue":"1","key":"2717_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/jsre.2001.6343","volume":"103","author":"DL Malone","year":"2002","unstructured":"Malone\u00a0DL, Genuit\u00a0T, Tracy\u00a0JK, Gannon\u00a0C, Napolitano\u00a0LM. Surgical Site Infections: Reanalysis of Risk Factors. Journal of Surgical Research. 2002;103(1):89\u201395. https:\/\/doi.org\/10.1006\/jsre.2001.6343.","journal-title":"Journal of Surgical Research"},{"issue":"6","key":"2717_CR20","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.bjps.2022.02.053","volume":"75","author":"Q Liu","year":"2022","unstructured":"Liu\u00a0Q, Aggarwal\u00a0A, Wu\u00a0M, et\u00a0al. Impact of diabetes on outcomes in breast reconstruction: A systematic review and meta-analysis. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2022;75(6):1793\u2013804. https:\/\/doi.org\/10.1016\/j.bjps.2022.02.053.","journal-title":"Journal of Plastic, Reconstructive & Aesthetic Surgery"},{"issue":"4","key":"2717_CR21","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1464-5491.2012.03582.x","volume":"29","author":"K Dhatariya","year":"2012","unstructured":"Dhatariya\u00a0K, Levy\u00a0N, Kilvert\u00a0A, et\u00a0al. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes*. Diabetic Medicine. 2012;29(4):420\u201333. https:\/\/doi.org\/10.1111\/j.1464-5491.2012.03582.x.","journal-title":"Diabetic Medicine"},{"issue":"2","key":"2717_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/neuros\/nyz405","volume":"87","author":"Z Pennington","year":"2020","unstructured":"Pennington\u00a0Z, Lubelski\u00a0D, Westbroek\u00a0EM, Ahmed\u00a0AK, Passias\u00a0PG, Sciubba\u00a0DM. Persistent Postoperative Hyperglycemia as a Risk Factor for Operative Treatment of Deep Wound Infection After Spine Surgery. Neurosurgery. 2020;87(2):211\u20139. https:\/\/doi.org\/10.1093\/neuros\/nyz405.","journal-title":"Neurosurgery"},{"issue":"S1","key":"2717_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/anae.14510","volume":"74","author":"N Levy","year":"2019","unstructured":"Levy\u00a0N, Dhatariya\u00a0K. Pre-operative optimisation of the surgical patient with diagnosed and undiagnosed diabetes: a\u00a0practical review. Anaesthesia. 2019;74(S1):58\u201366. https:\/\/doi.org\/10.1111\/anae.14510.","journal-title":"Anaesthesia"},{"issue":"3","key":"2717_CR24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14031","volume":"13","author":"SR Bennett","year":"2022","unstructured":"Bennett\u00a0SR, Alayesh\u00a0YM, Algarni\u00a0AM, et\u00a0al. Effect of Acute Stress Glycemic Control and Long-Term Glycemic Control on the Incidence of Post-Operative Infection in Diabetics Undergoing Cardiac Surgery. Cureus. 2022;13(3)e14031. https:\/\/doi.org\/10.7759\/cureus.14031.","journal-title":"Cureus"},{"issue":"6","key":"2717_CR25","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.athoracsur.2014.02.047","volume":"97","author":"H Zhang","year":"2014","unstructured":"Zhang\u00a0H, Yuan\u00a0X, Osnabrugge\u00a0RLJ, et\u00a0al. Influence of Diabetes Mellitus on Long-Term Clinical and Economic Outcomes After Coronary Artery Bypass Grafting. Ann Thorac Surg. 2014;97(6):2073\u20139. https:\/\/doi.org\/10.1016\/j.athoracsur.2014.02.047.","journal-title":"The Annals of Thoracic Surgery"},{"issue":"8","key":"2717_CR26","first-page":"607","volume":"103","author":"SC Chuang","year":"2004","unstructured":"Chuang\u00a0SC, Lee\u00a0KT, Chang\u00a0WT, et\u00a0al. Risk factors for wound infection after cholecystectomy. J\u00a0Formos Med Assoc. 2004;103(8):607\u201312.","journal-title":"J Formos Med Assoc"},{"key":"2717_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2021.110375","volume":"74","author":"SM Dougherty","year":"2021","unstructured":"Dougherty\u00a0SM, Schommer\u00a0J, Salinas\u00a0JL, et\u00a0al. Immediate preoperative hyperglycemia correlates with complications in non-cardiac surgical cases. J\u00a0Clin Anesth. 2021;74:110375. https:\/\/doi.org\/10.1016\/j.jclinane.2021.110375.","journal-title":"Journal of Clinical Anesthesia"},{"issue":"5","key":"2717_CR28","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/SLA.0000000000002323","volume":"267","author":"R Garg","year":"2018","unstructured":"Garg\u00a0R, Schuman\u00a0B, Bader\u00a0A, et\u00a0al. Effect of Preoperative Diabetes Management on Glycemic Control and Clinical Outcomes After Elective Surgery. Annals of Surgery. 2018;267(5):858\u201362. https:\/\/doi.org\/10.1097\/SLA.0000000000002323.","journal-title":"Annals of Surgery"},{"issue":"8","key":"2717_CR29","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.4239\/wjd.v12.i8.1255","volume":"12","author":"U Galway","year":"2021","unstructured":"Galway\u00a0U, Chahar\u00a0P, Schmidt\u00a0MT, et\u00a0al. Perioperative challenges in management of diabetic patients undergoing non-cardiac surgery. World J Diabetes. 2021;12(8):1255\u201366. https:\/\/doi.org\/10.4239\/wjd.v12.i8.1255.","journal-title":"World J Diabetes"},{"key":"2717_CR30","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac278","volume":"107","author":"MT Korytkowski","year":"2022","unstructured":"Korytkowski\u00a0MT, Muniyappa\u00a0R, Antinori-Lent\u00a0K, et\u00a0al. Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline. JCEM Case Rep. 2022;dgac278. https:\/\/doi.org\/10.1210\/clinem\/dgac278.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"2717_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S2213-8587(17)30097-9","volume":"5","author":"C Bommer","year":"2017","unstructured":"Bommer\u00a0C, Heesemann\u00a0E, Sagalova\u00a0V, et\u00a0al. The global economic burden of diabetes in adults aged 20\u201379 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 2017;5(6):423\u201330. https:\/\/doi.org\/10.1016\/S2213-8587(17)30097-9.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2717_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-8-29","volume":"8","author":"JP Boyle","year":"2010","unstructured":"Boyle\u00a0JP, Thompson\u00a0TJ, Gregg\u00a0EW, Barker\u00a0LE, Williamson\u00a0DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29. https:\/\/doi.org\/10.1186\/1478-7954-8-29.","journal-title":"Popul Health Metr"},{"issue":"11","key":"2717_CR33","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.2337\/diacare.17.11.1320","volume":"17","author":"S Aro","year":"1994","unstructured":"Aro\u00a0S, Kangas\u00a0T, Reunanen\u00a0A, Salinto\u00a0M, Koivisto\u00a0V. Hospital use among diabetic patients and the general population. Diabetes Care. 1994;17(11):1320\u20139. https:\/\/doi.org\/10.2337\/diacare.17.11.1320.","journal-title":"Diabetes Care"},{"issue":"12","key":"2717_CR34","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.2337\/diacare.23.12.1774","volume":"23","author":"PT Donnan","year":"2000","unstructured":"Donnan\u00a0PT, Leese\u00a0GP, Morris\u00a0AD, Diabetes Audit and Research in Tayside, Scotland\/Medicine Monitoring Unit Collaboration. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. Diabetes Care. 2000;23(12):1774\u20139. https:\/\/doi.org\/10.2337\/diacare.23.12.1774.","journal-title":"Diabetes Care"},{"issue":"3","key":"2717_CR35","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","volume":"87","author":"GE Umpierrez","year":"2002","unstructured":"Umpierrez\u00a0GE, Isaacs\u00a0SD, Bazargan\u00a0N, You\u00a0X, Thaler\u00a0LM, Kitabchi\u00a0AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J\u00a0Clin Endocrinol Metab. 2002;87(3):978\u201382. https:\/\/doi.org\/10.1210\/jcem.87.3.8341.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2717_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jdiacomp.2018.04.007","volume":"32","author":"RG McCoy","year":"2018","unstructured":"McCoy\u00a0RG, Herrin\u00a0J, Lipska\u00a0KJ, Shah\u00a0ND. Recurrent hospitalizations for severe hypoglycemia and hyperglycemia among U.S. adults with diabetes. J\u00a0Diabetes Complications. 2018;32(7):693\u2013701. https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.04.007.","journal-title":"J Diabetes Complications"},{"issue":"10","key":"2717_CR37","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s11606-017-4095-x","volume":"32","author":"RG McCoy","year":"2017","unstructured":"McCoy\u00a0RG, Lipska\u00a0KJ, Herrin\u00a0J, Jeffery\u00a0MM, Krumholz\u00a0HM, Shah\u00a0ND. Hospital Readmissions among Commercially Insured and Medicare Advantage Beneficiaries with Diabetes and the Impact of Severe Hypoglycemic and Hyperglycemic Events. J\u00a0Gen Intern Med. 2017;32(10):1097\u2013105. https:\/\/doi.org\/10.1007\/s11606-017-4095-x.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"2717_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063675","volume":"8","author":"F Lombardo","year":"2013","unstructured":"Lombardo\u00a0F, Maggini\u00a0M, Gruden\u00a0G, Bruno\u00a0G. Temporal Trend in Hospitalizations for Acute Diabetic Complications: A\u00a0Nationwide Study, Italy, 2001\u20132010. PLoS One. 2013;8(5)e63675. https:\/\/doi.org\/10.1371\/journal.pone.0063675.","journal-title":"PLOS ONE"},{"issue":"6","key":"2717_CR39","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.2337\/dc17-2304","volume":"41","author":"PH Yong","year":"2018","unstructured":"Yong\u00a0PH, Weinberg\u00a0L, Torkamani\u00a0N, et\u00a0al. The Presence of Diabetes and Higher HbA1c Are Independently Associated With Adverse Outcomes After Surgery. Diabetes Care. 2018;41(6):1172\u20139. https:\/\/doi.org\/10.2337\/dc17-2304.","journal-title":"Diabetes Care"},{"issue":"1","key":"2717_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.diabres.2006.10.017","volume":"77","author":"I Gornik","year":"2007","unstructured":"Gornik\u00a0I, Gornik\u00a0O, Gasparovi\u0107\u00a0V. HbA1c is outcome predictor in diabetic patients with sepsis. Diabetes Res Clin Pract Suppl. 2007;77(1):120\u20135. https:\/\/doi.org\/10.1016\/j.diabres.2006.10.017.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2717_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12933-019-0970-6","volume":"18","author":"W Pan","year":"2019","unstructured":"Pan\u00a0W, Lu\u00a0H, Lian\u00a0B, Liao\u00a0P, Guo\u00a0L, Zhang\u00a0M. Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis. Cardiovasc Diabetol. 2019;18(1):169\u2013169. https:\/\/doi.org\/10.1186\/s12933-019-0970-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"13","key":"2717_CR42","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","volume":"360","author":"S Finfer","year":"2009","unstructured":"NICE-SUGAR Study Investigators, Finfer\u00a0S, Chittock\u00a0DR, et\u00a0al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283\u201397. https:\/\/doi.org\/10.1056\/NEJMoa0810625.","journal-title":"N Engl J Med"},{"issue":"13","key":"2717_CR43","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","volume":"360","author":"S Finfer","year":"2009","unstructured":"NICE-SUGAR Study Investigators, Finfer\u00a0S, Chittock\u00a0DR, et\u00a0al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283\u201397. https:\/\/doi.org\/10.1056\/NEJMoa0810625.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"2717_CR44","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.2337\/dc18-S014","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. 14. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S144\u2013S51. https:\/\/doi.org\/10.2337\/dc18-S014.","journal-title":"Diabetes Care"},{"issue":"1","key":"2717_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/dc16-2215","volume":"40","author":"International Hypoglycaemia Study Group","year":"2017","unstructured":"International Hypoglycaemia Study Group. Glucose Concentrations of Less Than 3.0\u202fmmol\/L (54\u202fmg\/dL) Should Be Reported in Clinical Trials: A\u00a0Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2017;40(1):155\u20137. https:\/\/doi.org\/10.2337\/dc16-2215.","journal-title":"Diabetes Care"},{"issue":"6","key":"2717_CR46","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2337\/dc09-9029","volume":"32","author":"ES Moghissi","year":"2009","unstructured":"Moghissi\u00a0ES, Korytkowski\u00a0MT, DiNardo\u00a0M, et\u00a0al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119\u201331. https:\/\/doi.org\/10.2337\/dc09-9029.","journal-title":"Diabetes Care"},{"issue":"Supplement_1","key":"2717_CR47","doi-asserted-by":"publisher","first-page":"S321","DOI":"10.2337\/dc25-S016","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. Diabetes Care in the Hospital: Standards of Care in Diabetes\u20142025. Diabetes Care. 2024;48(Supplement_1):S321\u2013S34. https:\/\/doi.org\/10.2337\/dc25-S016.","journal-title":"Diabetes Care"},{"key":"2717_CR48","unstructured":"Wallmeier M. Positionspapier der Deutschen Diabetes Gesellschaft zur Therapie des Diabetes mellitus im Krankenhaus. 2016. https:\/\/www.ddg.info\/fileadmin\/user_upload\/06_Gesundheitspolitik\/01_Stellungnahmen\/2018\/2018_Positionspapier_der_DDG_zur_Therapie_des_DM_im_Krankenhaus_2._revidierte_Fassung_Dreyer_2017_SV_30052017.pdf."},{"issue":"7","key":"2717_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14838","volume":"39","author":"QYD Qi","year":"2022","unstructured":"Qi\u00a0QYD, Kyi\u00a0M, Pemberton\u00a0E, Colman\u00a0PG, Fourlanos\u00a0S. The Pro-Diab Melbourne Perioperative Study: A structured pre-admission perioperative diabetes management plan to improve medication usage in elective surgery. Diabet Med. 2022;39(7)e14838. https:\/\/doi.org\/10.1111\/dme.14838.","journal-title":"Diabetic Medicine"},{"issue":"4","key":"2717_CR50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11892-019-1132-7","volume":"19","author":"NE Palermo","year":"2019","unstructured":"Palermo\u00a0NE, Garg\u00a0R. Perioperative Management of Diabetes Mellitus: Novel Approaches. Curr Diab Rep. 2019;19(4):14\u201314. https:\/\/doi.org\/10.1007\/s11892-019-1132-7.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"2717_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.22374\/cjgim.v16i1.435","volume":"16","author":"SM Ruzycki","year":"2021","unstructured":"Ruzycki\u00a0SM, Harrison\u00a0T, Cameron\u00a0A, Helmle\u00a0K, McKeen\u00a0J. Perioperative Glycemic Management for Patients with and without Diabetes: A Review for Internists. Canadian Journal of General Internal Medicine. 2021;16(1):17\u201323. https:\/\/doi.org\/10.22374\/cjgim.v16i1.435.","journal-title":"Canadian Journal of General Internal Medicine"},{"issue":"2","key":"2717_CR52","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2192568220948480","volume":"12","author":"AE Arrighi-Allisan","year":"2022","unstructured":"Arrighi-Allisan\u00a0AE, Neifert\u00a0SN, Gal\u00a0JS, et\u00a0al. Diabetes Is Predictive of Postoperative Outcomes and Readmission Following Posterior Lumbar Fusion. Global Spine J. 2022;12(2):229\u201336. https:\/\/doi.org\/10.1177\/2192568220948480.","journal-title":"Global Spine J"},{"issue":"6","key":"2717_CR53","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S2213-8587(17)30097-9","volume":"5","author":"C Bommer","year":"2017","unstructured":"Bommer\u00a0C, Heesemann\u00a0E, Sagalova\u00a0V, et\u00a0al. The global economic burden of diabetes in adults aged 20\u201379 years: a cost-of-illness study. The Lancet Diabetes & Endocrinology. 2017;5(6):423\u201330. https:\/\/doi.org\/10.1016\/S2213-8587(17)30097-9.","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"20","key":"2717_CR54","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1001\/archinte.159.20.2405","volume":"159","author":"SJ Jacober","year":"1999","unstructured":"Jacober\u00a0SJ, Sowers\u00a0JR. An Update on Perioperative Management of Diabetes. Archives of Internal Medicine. 1999;159(20):2405\u201311. https:\/\/doi.org\/10.1001\/archinte.159.20.2405.","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"2717_CR55","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.amjsurg.2018.10.024","volume":"218","author":"BG Nair","year":"2019","unstructured":"Nair\u00a0BG, Neradilek\u00a0MB, Newman\u00a0SF, Horibe\u00a0M. Association between acute phase perioperative glucose parameters and postoperative outcomes in diabetic and non-diabetic patients undergoing non-cardiac surgery. Am J Surg. 2019;218(2):302\u201310. https:\/\/doi.org\/10.1016\/j.amjsurg.2018.10.024.","journal-title":"The American Journal of Surgery"},{"key":"2717_CR56","unstructured":"AUSTRALIAN DIABETES SOCIETY. Peri-operative Diabetes Management Guidelines. 30. 2012."},{"key":"2717_CR57","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1016\/j.jcjd.2017.10.014","volume":"42","author":"J Malcolm","year":"2018","unstructured":"Malcolm\u00a0J, Halperin\u00a0I, Miller\u00a0DB, et\u00a0al. In-Hospital Management of Diabetes. Can J Diabetes. 2018;42:S115\u2013S23. https:\/\/doi.org\/10.1016\/j.jcjd.2017.10.014.","journal-title":"Canadian Journal of Diabetes"},{"issue":"2","key":"2717_CR58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-0043-112653","volume":"126","author":"J Kufeldt","year":"2018","unstructured":"Kufeldt\u00a0J, Kovarova\u00a0M, Adolph\u00a0M, et\u00a0al. Prevalence and Distribution of Diabetes Mellitus in a Maximum Care Hospital: Urgent Need for HbA1c-Screening. Synfacts. 2018;126(2):123\u20139. https:\/\/doi.org\/10.1055\/s-0043-112653.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2717_CR59","doi-asserted-by":"crossref","unstructured":"Deutsche Diabetes Gesellschaft (2018) S3-Leitlinie Therapie des Typ-1-Diabetes, 2.\u00a0Auflage. (2):109","DOI":"10.1055\/a-0604-8622"},{"issue":"12","key":"2717_CR60","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1016\/j.mayocp.2020.05.004","volume":"95","author":"CP Himes","year":"2020","unstructured":"Himes\u00a0CP, Ganesh\u00a0R, Wight\u00a0EC, Simha\u00a0V, Liebow\u00a0M. Perioperative Evaluation and Management of Endocrine Disorders. Mayo Clin Proc Digit Health. 2020;95(12):2760\u201374. https:\/\/doi.org\/10.1016\/j.mayocp.2020.05.004.","journal-title":"Mayo Clinic Proceedings"},{"issue":"2","key":"2717_CR61","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/193229681300700217","volume":"7","author":"KM Neubauer","year":"2013","unstructured":"Neubauer\u00a0KM, Schaupp\u00a0L, Plank\u00a0J, et\u00a0al. Failure to Control Hyperglycemia in NonCritically Ill Diabetes Patients despite Standard Glycemic Management in a Hospital Setting. J\u00a0Diabetes Sci Technol. 2013;7(2):402\u20139. https:\/\/doi.org\/10.1177\/193229681300700217.","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"2717_CR62","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jc.2011-2098","volume":"97","author":"GE Umpierrez","year":"2012","unstructured":"Umpierrez\u00a0GE, Hellman\u00a0R, Korytkowski\u00a0MT, et\u00a0al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J\u00a0Clin Endocrinol Metab. 2012;97(1):16\u201338. https:\/\/doi.org\/10.1210\/jc.2011-2098.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2717_CR63","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/dia.2014.0343","volume":"17","author":"L Schaupp","year":"2015","unstructured":"Schaupp\u00a0L, Donsa\u00a0K, Neubauer\u00a0KM, et\u00a0al. Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy. Diabetes Technol Ther. 2015;17(9):611\u20138. https:\/\/doi.org\/10.1089\/dia.2014.0343.","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"2717_CR64","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1210\/jc.2008-1441","volume":"94","author":"GE Umpierrez","year":"2009","unstructured":"Umpierrez\u00a0GE, Hor\u00a0T, Smiley\u00a0D, et\u00a0al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J\u00a0Clin Endocrinol Metab. 2009;94(2):564\u20139. https:\/\/doi.org\/10.1210\/jc.2008-1441.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2717_CR65","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2337\/diacare.27.2.553","volume":"27","author":"S Clement","year":"2004","unstructured":"Clement\u00a0S, Braithwaite\u00a0SS, Magee\u00a0MF, et\u00a0al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553\u201391. https:\/\/doi.org\/10.2337\/diacare.27.2.553.","journal-title":"Diabetes Care"},{"issue":"9","key":"2717_CR66","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.2337\/dc07-0295","volume":"30","author":"GE Umpierrez","year":"2007","unstructured":"Umpierrez\u00a0GE, Smiley\u00a0D, Zisman\u00a0A, et\u00a0al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181\u20136. https:\/\/doi.org\/10.2337\/dc07-0295.","journal-title":"Diabetes Care"},{"key":"2717_CR67","doi-asserted-by":"publisher","unstructured":"Rubin DJ, Rybin D, Doros G, McDonnell ME (2011) Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes. Diabetes Care 34(8):1723\u20131728. https:\/\/doi.org\/10.2337\/dc10-2434","DOI":"10.2337\/dc10-2434"},{"issue":"Supplement_1","key":"2717_CR68","doi-asserted-by":"publisher","DOI":"10.2337\/db18-2280-PUB","volume":"67","author":"R RAINER","year":"2018","unstructured":"RAINER\u00a0R, ELSAYED\u00a0H, ABERER\u00a0F, et\u00a0al. Diabetes Management in Hospitalized Patients with Type 2 Diabetes (T2D) during Fasting Periods. Diabetes. 2018;67(Supplement_1)2280-PUB. https:\/\/doi.org\/10.2337\/db18-2280-PUB.","journal-title":"Diabetes"},{"key":"2717_CR69","volume-title":"Diabetes facts and guidelines","author":"SE Inzucchi","year":"2011","unstructured":"Inzucchi\u00a0SE. Diabetes facts and guidelines. New Haven: Yale Diabetes Center; 2011."},{"issue":"6","key":"2717_CR70","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/dme.12756","volume":"32","author":"S George","year":"2015","unstructured":"George\u00a0S, Dale\u00a0J, Stanisstreet\u00a0D, Joint British Diabetes Societies (JBDS) for Inpatient Care, JBDS Medical VRIII Writing Group. A guideline for the use of variable rate intravenous insulin infusion in medical inpatients. Diabet Med. 2015;32(6):706\u201313. https:\/\/doi.org\/10.1111\/dme.12756.","journal-title":"Diabet Med"},{"issue":"3","key":"2717_CR71","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1089\/dia.2006.0015","volume":"9","author":"R Juneja","year":"2007","unstructured":"Juneja\u00a0R, Roudebush\u00a0C, Kumar\u00a0N, et\u00a0al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther. 2007;9(3):232\u201340. https:\/\/doi.org\/10.1089\/dia.2006.0015.","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"2717_CR72","doi-asserted-by":"publisher","first-page":"986","DOI":"10.2337\/dc17-er07d","volume":"40","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association. Erratum. Diabetes Care in the Hospital. Sec. 14. In Standards of Medical Care in Diabetes-2017. Diabetes Care. 2017;40(7):986\u2013986. https:\/\/doi.org\/10.2337\/dc17-er07d.","journal-title":"Diabetes Care"},{"issue":"11","key":"2717_CR73","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.2337\/db06-0855","volume":"55","author":"G Van den Berghe","year":"2006","unstructured":"Van den Berghe\u00a0G, Wilmer\u00a0A, Milants\u00a0I, et\u00a0al. Intensive insulin therapy in mixed medical\/surgical intensive care units: benefit versus harm. Diabetes. 2006;55(11):3151\u20139. https:\/\/doi.org\/10.2337\/db06-0855.","journal-title":"Diabetes"},{"issue":"1","key":"2717_CR74","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1097\/MJT.0000000000001078","volume":"27","author":"A P\u00e9rez","year":"2020","unstructured":"P\u00e9rez\u00a0A, Ramos\u00a0A, Carreras\u00a0G. Insulin Therapy in Hospitalized Patients. Am J Ther. 2020;27(1):e71\u2013e8. https:\/\/doi.org\/10.1097\/MJT.0000000000001078.","journal-title":"Am J Ther"},{"issue":"2","key":"2717_CR75","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2337\/diacare.27.2.461","volume":"27","author":"PA Goldberg","year":"2004","unstructured":"Goldberg\u00a0PA, Siegel\u00a0MD, Sherwin\u00a0RS, et\u00a0al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27(2):461\u20137. https:\/\/doi.org\/10.2337\/diacare.27.2.461.","journal-title":"Diabetes Care"},{"issue":"10 suppl 4","key":"2717_CR76","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.3949\/ccjm.76.s4.09","volume":"76","author":"LF Meneghini","year":"2009","unstructured":"Meneghini\u00a0LF. Perioperative management of diabetes: Translating evidence into practice. CCJM. 2009;76(10 suppl 4):S53\u2013S9. https:\/\/doi.org\/10.3949\/ccjm.76.s4.09.","journal-title":"CCJM"},{"issue":"18","key":"2717_CR77","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMcp060094","volume":"355","author":"SE Inzucchi","year":"2006","unstructured":"Inzucchi\u00a0SE. Management of Hyperglycemia in the Hospital Setting. N Engl J Med. 2006;355(18):1903\u201311. https:\/\/doi.org\/10.1056\/NEJMcp060094.","journal-title":"N Engl J Med"},{"issue":"11","key":"2717_CR78","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.4330\/wjc.v6.i11.1209","volume":"6","author":"P Reddy","year":"2014","unstructured":"Reddy\u00a0P, Duggar\u00a0B, Butterworth\u00a0J. Blood glucose management in the patient undergoing cardiac surgery: A\u00a0review. World J Cardiol. 2014;6(11):1209\u201317. https:\/\/doi.org\/10.4330\/wjc.v6.i11.1209.","journal-title":"World J Cardiol"},{"issue":"2","key":"2717_CR79","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2337\/dc10-1407","volume":"34","author":"GE Umpierrez","year":"2011","unstructured":"Umpierrez\u00a0GE, Smiley\u00a0D, Jacobs\u00a0S, et\u00a0al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34(2):256\u201361. https:\/\/doi.org\/10.2337\/dc10-1407.","journal-title":"Diabetes Care"},{"issue":"8","key":"2717_CR80","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2337\/dc12-1988","volume":"36","author":"GE Umpierrez","year":"2013","unstructured":"Umpierrez\u00a0GE, Smiley\u00a0D, Hermayer\u00a0K, et\u00a0al. Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes. Diabetes Care. 2013;36(8):2169\u201374. https:\/\/doi.org\/10.2337\/dc12-1988.","journal-title":"Diabetes Care"},{"issue":"4","key":"2717_CR81","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7326\/0003-4819-146-4-200702200-00002","volume":"146","author":"GY Gandhi","year":"2007","unstructured":"Gandhi\u00a0GY, Nuttall\u00a0GA, Abel\u00a0MD, et\u00a0al. Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery. Ann Intern Med. 2007;146(4):233\u201343. https:\/\/doi.org\/10.7326\/0003-4819-146-4-200702200-00002.","journal-title":"Ann Intern Med"},{"issue":"8","key":"2717_CR82","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/EJA.0b013e3283495ba1","volume":"28","author":"I Smith","year":"2011","unstructured":"Smith\u00a0I, Kranke\u00a0P, Murat\u00a0I, et\u00a0al. Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. European Journal of Anaesthesiology | EJA. 2011;28(8):556\u201369. https:\/\/doi.org\/10.1097\/EJA.0b013e3283495ba1.","journal-title":"European Journal of Anaesthesiology | EJA"},{"key":"2717_CR83","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jclinane.2016.10.003","volume":"36","author":"LJ Demma","year":"2017","unstructured":"Demma\u00a0LJ, Carlson\u00a0KT, Duggan\u00a0EW, Morrow\u00a0JG, Umpierrez\u00a0G. Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes. J\u00a0Clin Anesth. 2017;36:184\u20138. https:\/\/doi.org\/10.1016\/j.jclinane.2016.10.003.","journal-title":"Journal of Clinical Anesthesia"},{"key":"2717_CR84","unstructured":"Di\u00e4tologen: Neuerscheinung - neue Kohlenhydrattabelle. https:\/\/www.diaetologen.at\/news-detailansicht\/artikel\/neuerscheinung-neue-kohlenhydrattabelle\/. Accessed 19\u00a0June 2022"},{"issue":"4","key":"2717_CR85","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7326\/0003-4819-146-4-200702200-00002","volume":"146","author":"GY Gandhi","year":"2007","unstructured":"Gandhi\u00a0GY, Nuttall\u00a0GA, Abel\u00a0MD, Mullany\u00a0CJ, Schaff\u00a0HV, O\u2019Brien\u00a0PC, et\u00a0al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146(4):233\u201343.","journal-title":"Ann Intern Med"},{"issue":"8","key":"2717_CR86","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/EJA.0b013e3283495ba1","volume":"28","author":"I Smith","year":"2011","unstructured":"Smith\u00a0I, Kranke\u00a0P, Murat\u00a0I, et\u00a0al. Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2011;28(8):556\u201369. https:\/\/doi.org\/10.1097\/EJA.0b013e3283495ba1.","journal-title":"Eur J Anaesthesiol"},{"issue":"8","key":"2717_CR87","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2337\/dci24-0032","volume":"47","author":"GE Umpierrez","year":"2024","unstructured":"Umpierrez\u00a0GE, Davis\u00a0GM, ElSayed\u00a0NA, et\u00a0al. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care. 2024;47(8):1257\u201375. https:\/\/doi.org\/10.2337\/dci24-0032.","journal-title":"Diabetes Care"},{"issue":"18","key":"2717_CR88","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMcp060094","volume":"355","author":"SE Inzucchi","year":"2006","unstructured":"Inzucchi\u00a0SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355(18):1903\u201311. https:\/\/doi.org\/10.1056\/NEJMcp060094.","journal-title":"N Engl J Med"},{"issue":"6","key":"2717_CR89","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1210\/jc.2003-030347","volume":"88","author":"DL Trence","year":"2003","unstructured":"Trence\u00a0DL, Kelly\u00a0JL, Hirsch\u00a0IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J\u00a0Clin Endocrinol Metab. 2003;88(6):2430\u20137. https:\/\/doi.org\/10.1210\/jc.2003-030347.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2717_CR90","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2337\/dc16-0989","volume":"40","author":"GE Umpierrez","year":"2017","unstructured":"Umpierrez\u00a0GE, Pasquel\u00a0FJ. Management of Inpatient Hyperglycemia and Diabetes in Older Adults. Diabetes Care. 2017;40(4):509\u201317. https:\/\/doi.org\/10.2337\/dc16-0989.","journal-title":"Diabetes Care"},{"key":"2717_CR91","unstructured":"ESUR guidelines on Contrast Media - B. Renal adverse reactions. https:\/\/esur-cm.org\/index.php\/b-renal-adverse-reactions-2#B_4. Accessed 22\u00a0Dec 2025"},{"issue":"12","key":"2717_CR92","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","volume":"21","author":"F Stacul","year":"2011","unstructured":"Stacul\u00a0F, van der Molen\u00a0AJ, Reimer\u00a0P, et\u00a0al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21(12):2527\u201341. https:\/\/doi.org\/10.1007\/s00330-011-2225-0.","journal-title":"Eur Radiol"},{"issue":"6","key":"2717_CR93","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.kint.2016.09.010","volume":"90","author":"V Perkovic","year":"2016","unstructured":"Perkovic\u00a0V, Agarwal\u00a0R, Fioretto\u00a0P, et\u00a0al. Management of patients with diabetes and CKD: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference. Kidney Int. 2016;90(6):1175\u201383. https:\/\/doi.org\/10.1016\/j.kint.2016.09.010.","journal-title":"Kidney Int"},{"key":"2717_CR94","unstructured":"e.V DD\u2011G Positionspapier der DDG zur Therapie des DM im Krankenhaus. In: Deutsche Diabetes Gesellschaft e.\u202fV. https:\/\/www.ddg.info\/politik\/stellungnahmen\/krankenhaus. Accessed 10\u00a0Sept 2025"},{"issue":"11","key":"2717_CR95","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1111\/dom.12974","volume":"19","author":"JD Lalau","year":"2017","unstructured":"Lalau\u00a0JD, Kajbaf\u00a0F, Protti\u00a0A, Christensen\u00a0MM, De Broe\u00a0ME, Wiernsperger\u00a0N. Metformin-associated lactic acidosis (MALA): Moving towards a\u00a0new paradigm. Diabetes Obes Metab. 2017;19(11):1502\u201312. https:\/\/doi.org\/10.1111\/dom.12974.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"2717_CR96","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ajcp\/80.4.484","volume":"80","author":"D Luft","year":"1983","unstructured":"Luft\u00a0D, Deichsel\u00a0G, Schm\u00fclling\u00a0RM, Stein\u00a0W, Eggstein\u00a0M. Definition of clinically relevant lactic acidosis in patients with internal diseases. Am J Clin Pathol. 1983;80(4):484\u20139. https:\/\/doi.org\/10.1093\/ajcp\/80.4.484.","journal-title":"Am J Clin Pathol"},{"key":"2717_CR97","unstructured":"(2022) Metformin. In: BASG. https:\/\/www.basg.gv.at\/metformin. Accessed 27\u00a0June 2022"},{"issue":"7","key":"2717_CR98","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/j.1875-9114.2011.01088.x","volume":"32","author":"CM Deusenberry","year":"2012","unstructured":"Deusenberry\u00a0CM, Coley\u00a0KC, Korytkowski\u00a0MT, Donihi\u00a0AC. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy. 2012;32(7):613\u20137.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"2717_CR99","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/01.RES.0000052671.53256.49","volume":"92","author":"H Miura","year":"2003","unstructured":"Miura\u00a0H, Wachtel\u00a0RE, Loberiza\u00a0FR, et\u00a0al. Diabetes Mellitus Impairs Vasodilation to Hypoxia in Human Coronary Arterioles. Circulation Research. 2003;92(2):151\u20138. https:\/\/doi.org\/10.1161\/01.RES.0000052671.53256.49.","journal-title":"Circulation Research"},{"issue":"6","key":"2717_CR100","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00101-020-00875-7","volume":"70","author":"B Rupprecht","year":"2021","unstructured":"Rupprecht\u00a0B, St\u00f6ckl\u00a0A, St\u00f6ckl\u00a0S, Dietrich\u00a0C. Therapie des Diabetes mellitus in der perioperativen Medizin \u2013 ein Update. Anaesthesiologie. 2021;70(6):451\u201365. https:\/\/doi.org\/10.1007\/s00101-020-00875-7.","journal-title":"Anaesthesist"},{"issue":"2","key":"2717_CR101","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/ALN.0000000000003237","volume":"133","author":"JC Preiser","year":"2020","unstructured":"Preiser\u00a0JC, Provenzano\u00a0B, Mongkolpun\u00a0W, Halenarova\u00a0K, Cnop\u00a0M. Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes. Anesthesiology. 2020;133(2):430\u20138. https:\/\/doi.org\/10.1097\/ALN.0000000000003237.","journal-title":"Anesthesiology"},{"issue":"3","key":"2717_CR102","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/ACO.0000000000000735","volume":"32","author":"D Kuzulugil","year":"2019","unstructured":"Kuzulugil\u00a0D, Papeix\u00a0G, Luu\u00a0J, Kerridge\u00a0RK. Recent advances in diabetes treatments and their perioperative implications. Current Opinion in Anesthesiology. 2019;32(3):398\u2013404. https:\/\/doi.org\/10.1097\/ACO.0000000000000735.","journal-title":"Current Opinion in Anesthesiology"},{"issue":"2","key":"2717_CR103","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S2213-8587(16)30402-8","volume":"5","author":"FJ Pasquel","year":"2017","unstructured":"Pasquel\u00a0FJ, Gianchandani\u00a0R, Rubin\u00a0DJ, et\u00a0al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol. 2017;5(2):125\u201333. https:\/\/doi.org\/10.1016\/S2213-8587(16)30402-8.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2717_CR104","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.2337\/dc13-0277","volume":"36","author":"GE Umpierrez","year":"2013","unstructured":"Umpierrez\u00a0GE, Gianchandani\u00a0R, Smiley\u00a0D, et\u00a0al. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study. Diabetes Care. 2013;36(11):3430\u20135. https:\/\/doi.org\/10.2337\/dc13-0277.","journal-title":"Diabetes Care"},{"key":"2717_CR105","unstructured":"Research C for DE and (2019) FDA Drug Safety Communication: FDA adds warnings about heart failure risk to labels of type\u00a02 diabetes medicines containing saxagliptin and alogliptin. FDA"},{"issue":"1","key":"2717_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2197-4","volume":"22","author":"AH Hulst","year":"2018","unstructured":"Hulst\u00a0AH, Plummer\u00a0MP, Hollmann\u00a0MW, et\u00a0al. Systematic review of incretin therapy during peri-operative and intensive care. Crit Care. 2018;22(1)299. https:\/\/doi.org\/10.1186\/s13054-018-2197-4.","journal-title":"Crit Care"},{"key":"2717_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-015-0005-5","volume":"1","author":"JJ Macdonald","year":"2015","unstructured":"Macdonald\u00a0JJ, Neupane\u00a0S, Gianchandani\u00a0RY. The potential role of incretin therapy in the hospital setting. Clin Diabetes Endocrinol. 2015;1:4. https:\/\/doi.org\/10.1186\/s40842-015-0005-5.","journal-title":"Clin Diabetes Endocrinol"},{"issue":"4","key":"2717_CR108","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/dom.13587","volume":"21","author":"P Vellanki","year":"2019","unstructured":"Vellanki\u00a0P, Rasouli\u00a0N, Baldwin\u00a0D, et\u00a0al. Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial. Diabetes Obes Metab. 2019;21(4):837\u201343. https:\/\/doi.org\/10.1111\/dom.13587.","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"2717_CR109","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jdiacomp.2018.08.014","volume":"32","author":"M Fayfman","year":"2018","unstructured":"Fayfman\u00a0M, Davis\u00a0G, Duggan\u00a0EW, et\u00a0al. Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study. J\u00a0Diabetes Complications. 2018;32(12):1091\u20136. https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.08.014.","journal-title":"J Diabetes Complications"},{"issue":"2","key":"2717_CR110","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/dom.14241","volume":"23","author":"S Cardona","year":"2021","unstructured":"Cardona\u00a0S, Tsegka\u00a0K, Pasquel\u00a0FJ, et\u00a0al. Sitagliptin for the prevention and treatment of perioperative hyperglycaemia in patients with type 2 diabetes undergoing cardiac surgery: A randomized controlled trial. Diabetes Obes Metab. 2021;23(2):480\u20138. https:\/\/doi.org\/10.1111\/dom.14241.","journal-title":"Diabetes Obes Metab"},{"issue":"19","key":"2717_CR111","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso\u00a0SP, Bain\u00a0SC, Consoli\u00a0A, et\u00a0al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016;375(19):1834\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1607141.","journal-title":"N Engl J Med"},{"issue":"4","key":"2717_CR112","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso\u00a0SP, Daniels\u00a0GH, Brown-Frandsen\u00a0K, et\u00a0al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016;375(4):311\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1603827.","journal-title":"N Engl J Med"},{"issue":"10157","key":"2717_CR113","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","volume":"392","author":"AF Hernandez","year":"2018","unstructured":"Hernandez\u00a0AF, Green\u00a0JB, Janmohamed\u00a0S, et\u00a0al. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. Lancet. 2018;392(10157):1519\u201329. https:\/\/doi.org\/10.1016\/S0140-6736(18)32261-X.","journal-title":"Lancet"},{"issue":"10193","key":"2717_CR114","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein\u00a0HC, Colhoun\u00a0HM, Dagenais\u00a0GR, et\u00a0al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. The Lancet. 2019;394(10193):121\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(19)31149-3.","journal-title":"The Lancet"},{"issue":"4","key":"2717_CR115","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cgh.2023.11.002","volume":"22","author":"JG Hashash","year":"2024","unstructured":"Hashash\u00a0JG, Thompson\u00a0CC, Wang\u00a0AY. AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP\u20111 Receptor Agonists Prior to Endoscopy: Communication. Clin Gastroenterol Hepatol. 2024;22(4):705\u20137. https:\/\/doi.org\/10.1016\/j.cgh.2023.11.002.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"2717_CR116","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.gie.2024.10.057","volume":"101","author":"RZ Sharaiha","year":"2025","unstructured":"Sharaiha\u00a0RZ, Shukla\u00a0AP, Sen\u00a0S, et\u00a0al. American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide\u20111 receptor agonists and sodium-glucose cotransporter\u20112 inhibitors. Gastrointestinal Endoscopy. 2025;101(2):285\u201394. https:\/\/doi.org\/10.1016\/j.gie.2024.10.057.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"2717_CR117","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/anae.16541","volume":"80","author":"K El-Boghdadly","year":"2025","unstructured":"El-Boghdadly\u00a0K, Dhesi\u00a0J, Fabb\u00a0P, et\u00a0al. Elective peri-operative management of adults taking glucagon-like peptide\u20111 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter\u20112 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association. Anaesthesia. 2025;80(4):412\u201324. https:\/\/doi.org\/10.1111\/anae.16541.","journal-title":"Anaesthesia"},{"issue":"1","key":"2717_CR118","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00464-024-11263-2","volume":"39","author":"TL Kindel","year":"2025","unstructured":"Kindel\u00a0TL, Wang\u00a0AY, Wadhwa\u00a0A, et\u00a0al. Multi-society clinical practice guidance for the safe use of glucagon-like peptide\u20111 receptor agonists in the perioperative period. Surg Endosc. 2025;39(1):180\u20133. https:\/\/doi.org\/10.1007\/s00464-024-11263-2.","journal-title":"Surg Endosc"},{"key":"2717_CR119","unstructured":"Lilly\u2019s Mounjaro (tirzepatide), a\u00a0GIP\/GLP\u20111 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type\u00a02 diabetes and heart disease | Eli Lilly and Company. https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lillys-mounjaro-tirzepatide-gipglp-1-dual-agonist-demonstrated. Accessed 10\u00a0Sept 2025"},{"issue":"4","key":"2717_CR120","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/anae.16541","volume":"80","author":"K El-Boghdadly","year":"2025","unstructured":"El-Boghdadly\u00a0K, Dhesi\u00a0J, Fabb\u00a0P, et\u00a0al. Elective peri-operative management of adults taking glucagon-like peptide\u20111 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter\u20112 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association. Anaesthesia. 2025;80(4):412\u201324. https:\/\/doi.org\/10.1111\/anae.16541.","journal-title":"Anaesthesia"},{"issue":"22","key":"2717_CR121","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman\u00a0B, Wanner\u00a0C, Lachin\u00a0JM, et\u00a0al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. New England Journal of Medicine. 2015;373(22):2117\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1504720.","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"2717_CR122","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrendo.2016.15","volume":"12","author":"G Umpierrez","year":"2016","unstructured":"Umpierrez\u00a0G, Korytkowski\u00a0M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222\u201332. https:\/\/doi.org\/10.1038\/nrendo.2016.15.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2717_CR123","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","volume":"28","author":"AA Voors","year":"2022","unstructured":"Voors\u00a0AA, Angermann\u00a0CE, Teerlink\u00a0JR, et\u00a0al. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat Med. 2022;28(3):568\u201374. https:\/\/doi.org\/10.1038\/s41591-021-01659-1.","journal-title":"Nat Med"},{"issue":"16","key":"2717_CR124","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1056\/NEJMoa2314051","volume":"390","author":"J Butler","year":"2024","unstructured":"Butler\u00a0J, Jones\u00a0WS, Udell\u00a0JA, et\u00a0al. Empagliflozin after Acute Myocardial Infarction. New England Journal of Medicine. 2024;390(16):1455\u201366. https:\/\/doi.org\/10.1056\/NEJMoa2314051.","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"2717_CR125","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2337\/dc20-1983","volume":"44","author":"P Wolf","year":"2021","unstructured":"Wolf\u00a0P, Fellinger\u00a0P, Pfleger\u00a0L, et\u00a0al. Gluconeogenesis, But Not Glycogenolysis, Contributes to the Increase in Endogenous Glucose Production by SGLT\u20112 Inhibition. Diabetes Care. 2021;44(2):541\u20138. https:\/\/doi.org\/10.2337\/dc20-1983.","journal-title":"Diabetes Care"},{"issue":"6","key":"2717_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102275","volume":"15","author":"N Menghoum","year":"2021","unstructured":"Menghoum\u00a0N, Oriot\u00a0P, Hermans\u00a0MP. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated with SGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes Metab Syndr. 2021;15(6)102275. https:\/\/doi.org\/10.1016\/j.dsx.2021.102275.","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews"},{"issue":"1","key":"2717_CR127","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/dom.13012","volume":"20","author":"BM Bonora","year":"2018","unstructured":"Bonora\u00a0BM, Avogaro\u00a0A, Fadini\u00a0GP. Sodium-glucose co-transporter\u20112 inhibitors and diabetic ketoacidosis: An updated review of the literature. Diabetes Obes Metab. 2018;20(1):25\u201333. https:\/\/doi.org\/10.1111\/dom.13012.","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"2717_CR128","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znab390","volume":"108","author":"AT Kietaibl","year":"2021","unstructured":"Kietaibl\u00a0AT, Fasching\u00a0P, Glaser\u00a0K, Petter-Puchner\u00a0AH. Acute abdomen as a\u00a0side-effect of sodium-glucose co-transporter 2\u00a0inhibitors in diabetic patients. Br J Surg. 2021;108(12)e409. https:\/\/doi.org\/10.1093\/bjs\/znab390.","journal-title":"Br J Surg"},{"issue":"8","key":"2717_CR129","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/anae.14251","volume":"73","author":"DA Milder","year":"2018","unstructured":"Milder\u00a0DA, Milder\u00a0TY, Kam\u00a0PCA. Sodium-glucose co-transporter type\u20112 inhibitors: pharmacology and peri-operative considerations. Anaesthesia. 2018;73(8):1008\u201318. https:\/\/doi.org\/10.1111\/anae.14251.","journal-title":"Anaesthesia"},{"issue":"5","key":"2717_CR130","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00228-020-03051-3","volume":"77","author":"AO Bamgboye","year":"2021","unstructured":"Bamgboye\u00a0AO, Oni\u00a0IO, Collier\u00a0A. Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type\u00a02 diabetes patients on SGLT2-inhibitors: a\u00a0review. Eur J Clin Pharmacol. 2021;77(5):651\u20137. https:\/\/doi.org\/10.1007\/s00228-020-03051-3.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"2717_CR131","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bja.2019.03.028","volume":"123","author":"V Thiruvenkatarajan","year":"2019","unstructured":"Thiruvenkatarajan\u00a0V, Meyer\u00a0EJ, Nanjappa\u00a0N, Van Wijk\u00a0RM, Jesudason\u00a0D. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter\u20112 inhibitors: a systematic review. Br J Anaesth. 2019;123(1):27\u201336. https:\/\/doi.org\/10.1016\/j.bja.2019.03.028.","journal-title":"Br J Anaesth"},{"key":"2717_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.828649","volume":"9","author":"AT Kietaibl","year":"2022","unstructured":"Kietaibl\u00a0AT, Fasching\u00a0P, Glaser\u00a0K, Petter-Puchner\u00a0AH. New Diabetic Medication Sodium-Glucose Cotransporter\u20112 Inhibitors Can Induce Euglycemic Ketoacidosis and Mimic Surgical Diseases: A Case Report and Review of Literature. Front Surg. 2022;9:828649. https:\/\/doi.org\/10.3389\/fsurg.2022.828649.","journal-title":"Front Surg"},{"key":"2717_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2021.110201","volume":"71","author":"JPJ Pontes","year":"2021","unstructured":"Pontes\u00a0JPJ, de Melo\u00a0CS, Arantes\u00a0FBB, de Souza Ramos\u00a0JTG, M\u00f3dolo\u00a0NSP, Navarro e Lima\u00a0LH. Perioperative euglycemic diabetic ketoacidosis following use of SGLT-2\u00a0inhibitors after cardiac surgery. J\u00a0Clin Anesth. 2021;71:110201. https:\/\/doi.org\/10.1016\/j.jclinane.2021.110201.","journal-title":"Journal of Clinical Anesthesia"},{"key":"2717_CR134","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ajem.2021.02.015","volume":"44","author":"B Long","year":"2021","unstructured":"Long\u00a0B, Lentz\u00a0S, Koyfman\u00a0A, Gottlieb\u00a0M. Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management. Am J Emerg Med. 2021;44:157\u201360. https:\/\/doi.org\/10.1016\/j.ajem.2021.02.015.","journal-title":"Am J Emerg Med"},{"issue":"2","key":"2717_CR135","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12630-017-1018-6","volume":"65","author":"A Lau","year":"2018","unstructured":"Lau\u00a0A, Bruce\u00a0S, Wang\u00a0E, Ree\u00a0R, Rondi\u00a0K, Chau\u00a0A. Perioperative implications of sodium-glucose cotransporter\u20112 inhibitors: a case series of euglycemic diabetic ketoacidosis in three patients after cardiac surgery. Can J Anaesth. 2018;65(2):188\u201393. https:\/\/doi.org\/10.1007\/s12630-017-1018-6.","journal-title":"Can J Anaesth"},{"key":"2717_CR136","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13665","author":"MR Somagutta","year":"2021","unstructured":"Somagutta\u00a0MR, Agadi\u00a0K, Hange\u00a0N, et\u00a0al. Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter\u20112 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers. Cureus. 2021; https:\/\/doi.org\/10.7759\/cureus.13665.","journal-title":"Cureus"},{"issue":"2","key":"2717_CR137","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1213\/ANE.0000000000002740","volume":"126","author":"JA DeCou","year":"2018","unstructured":"DeCou\u00a0JA, Sams\u00a0SH. New Diabetes Medications Raise New Perioperative Concerns for the Anesthesiologist. Anesthesia Analgesia. 2018;126(2):390\u20132. https:\/\/doi.org\/10.1213\/ANE.0000000000002740.","journal-title":"Anesthesia Analgesia"},{"key":"2717_CR138","unstructured":"Khan N MD, MSc, Ghali W MD, MPH, Cagliero E MD. Perioperative management of blood glucose in adults with diabetes mellitus. 2021."},{"issue":"5","key":"2717_CR139","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s00101-024-01408-2","volume":"73","author":"C Z\u00f6llner","year":"2024","unstructured":"Z\u00f6llner\u00a0C, B\u00f6hmer\u00a0A, Geldner\u00a0G, et\u00a0al. Pr\u00e4operative Evaluation erwachsener Patientinnen und Patienten vor elektiven, nicht herz-thoraxchirurgischen Eingriffen. Anaesthesiologie. 2024;73(5):294\u2013323. https:\/\/doi.org\/10.1007\/s00101-024-01408-2.","journal-title":"Anaesthesiologie"},{"issue":"1","key":"2717_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/EJA.0000000000002069","volume":"42","author":"M Lamperti","year":"2025","unstructured":"Lamperti\u00a0M, Romero\u00a0CS, Guarracino\u00a0F, et\u00a0al. Preoperative assessment of adults undergoing elective noncardiac surgery: Updated guidelines from the European Society of Anaesthesiology and Intensive Care. European Journal of Anaesthesiology. 2025;42(1):1\u201335. https:\/\/doi.org\/10.1097\/EJA.0000000000002069.","journal-title":"European Journal of Anaesthesiology"},{"issue":"4","key":"2717_CR141","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/anae.16541","volume":"80","author":"K El-Boghdadly","year":"2025","unstructured":"El-Boghdadly\u00a0K, Dhesi\u00a0J, Fabb\u00a0P, et\u00a0al. Elective peri-operative management of adults taking glucagon-like peptide\u20111 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter\u20112 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association. Anaesthesia. 2025;80(4):412\u201324. https:\/\/doi.org\/10.1111\/anae.16541.","journal-title":"Anaesthesia"},{"issue":"6","key":"2717_CR142","doi-asserted-by":"publisher","first-page":"753","DOI":"10.4158\/EP161292.PS","volume":"22","author":"Y Handelsman","year":"2016","unstructured":"Handelsman\u00a0Y, Henry\u00a0RR, Bloomgarden\u00a0ZT, et\u00a0al. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT\u20112 Inhibitors and Diabetic Ketoacidosis. Endocrine Practice. 2016;22(6):753\u201362. https:\/\/doi.org\/10.4158\/EP161292.PS.","journal-title":"Endocrine Practice"},{"key":"2717_CR143","unstructured":"Australian Diabetes Society. Severe euglycaemic ketoacidosis with SGLT2 inhibitor use in the perioperative period. 2021."},{"key":"2717_CR144","unstructured":"Traill DR Severe euglycaemic ketoacidosis with SGLT2 inhibitor use in the perioperative period."},{"issue":"9","key":"2717_CR145","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2337\/dc15-0843","volume":"38","author":"AL Peters","year":"2015","unstructured":"Peters\u00a0AL, Buschur\u00a0EO, Buse\u00a0JB, Cohan\u00a0P, Diner\u00a0JC, Hirsch\u00a0IB. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium\u2013Glucose Cotransporter 2 Inhibition. Diabetes Care. 2015;38(9):1687\u201393. https:\/\/doi.org\/10.2337\/dc15-0843.","journal-title":"Diabetes Care"},{"issue":"2","key":"2717_CR146","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1213\/ANE.0000000000002377","volume":"126","author":"SC Peacock","year":"2018","unstructured":"Peacock\u00a0SC, Lovshin\u00a0JA, Cherney\u00a0DZI. Perioperative Considerations for the Use of Sodium-Glucose Cotransporter\u20112 Inhibitors in Patients With Type 2 Diabetes. Anesthesia Analgesia. 2018;126(2):699\u2013704. https:\/\/doi.org\/10.1213\/ANE.0000000000002377.","journal-title":"Anesthesia Analgesia"},{"key":"2717_CR147","unstructured":"Research C for DE and (2021) FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections. FDA"},{"issue":"8","key":"2717_CR148","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4239\/wjd.v6.i8.1073","volume":"6","author":"HE Tamez-P\u00e9rez","year":"2015","unstructured":"Tamez-P\u00e9rez\u00a0HE, Quintanilla-Flores\u00a0DL, Rodr\u00edguez-Guti\u00e9rrez\u00a0R, Gonz\u00e1lez-Gonz\u00e1lez\u00a0JG, Tamez-Pe\u00f1a\u00a0AL. Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review. World J Diabetes. 2015;6(8):1073\u201381. https:\/\/doi.org\/10.4239\/wjd.v6.i8.1073.","journal-title":"World J Diabetes"},{"issue":"2","key":"2717_CR149","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.diabres.2015.02.010","volume":"108","author":"T Katsuyama","year":"2015","unstructured":"Katsuyama\u00a0T, Sada\u00a0KE, Namba\u00a0S, et\u00a0al. Risk factors for the development of glucocorticoid-induced diabetes mellitus. Diabetes Res Clin Pract Suppl. 2015;108(2):273\u20139. https:\/\/doi.org\/10.1016\/j.diabres.2015.02.010.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"2717_CR150","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.bbmt.2017.03.010","volume":"23","author":"MN Stauber","year":"2017","unstructured":"Stauber\u00a0MN, Aberer\u00a0F, Oulhaj\u00a0A, et\u00a0al. Early Hyperglycemia after Initiation of Glucocorticoid Therapy Predicts Adverse Outcome in Patients with Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2017;23(7):1186\u201392. https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.010.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2717_CR151","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/sj.ki.5000116","volume":"69","author":"J Hjelmesaeth","year":"2006","unstructured":"Hjelmesaeth\u00a0J, Hartmann\u00a0A, Leivestad\u00a0T, et\u00a0al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int. 2006;69(3):588\u201395. https:\/\/doi.org\/10.1038\/sj.ki.5000116.","journal-title":"Kidney Int"},{"issue":"10","key":"2717_CR152","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102154","volume":"10","author":"F Aberer","year":"2021","unstructured":"Aberer\u00a0F, Hochfellner\u00a0DA, Sourij\u00a0H, Mader\u00a0JK. A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital. J\u00a0Clin Med. 2021;10(10)2154. https:\/\/doi.org\/10.3390\/jcm10102154.","journal-title":"J Clin Med"},{"key":"2717_CR153","unstructured":"JDBP-IP. Management of Hyperglycaemia and Steroid (Glucocorticoid) Therapy. 2023."},{"issue":"5","key":"2717_CR154","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4158\/EP08331.RAR","volume":"15","author":"JN Clore","year":"2009","unstructured":"Clore\u00a0JN, Thurby-Hay\u00a0L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15(5):469\u201374. https:\/\/doi.org\/10.4158\/EP08331.RAR.","journal-title":"Endocr Pract"},{"issue":"4","key":"2717_CR155","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1177\/1932296820932903","volume":"14","author":"RJ Galindo","year":"2020","unstructured":"Galindo\u00a0RJ, Aleppo\u00a0G, Klonoff\u00a0DC, et\u00a0al. Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic. J\u00a0Diabetes Sci Technol. 2020;14(4):822\u201332. https:\/\/doi.org\/10.1177\/1932296820932903.","journal-title":"J Diabetes Sci Technol"},{"issue":"12","key":"2717_CR156","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.2337\/dci24-0073","volume":"47","author":"JLV Shaw","year":"2024","unstructured":"Shaw\u00a0JLV, Bannuru\u00a0RR, Beach\u00a0L, et\u00a0al. Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings. Diabetes Care. 2024;47(12):2062\u201375. https:\/\/doi.org\/10.2337\/dci24-0073.","journal-title":"Diabetes Care"},{"issue":"3","key":"2717_CR157","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15452","volume":"42","author":"P Avari","year":"2025","unstructured":"Avari\u00a0P, Choudhary\u00a0P, Lumb\u00a0A, et\u00a0al. Using technology to support diabetes care in hospital: Guidelines from the Joint British Diabetes Societies for Inpatient Care (JBDS-IP) group and Diabetes Technology Network (DTN) UK. Diabet Med. 2025;42(3)e15452. https:\/\/doi.org\/10.1111\/dme.15452.","journal-title":"Diabetic Medicine"},{"issue":"8","key":"2717_CR158","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1210\/clinem\/dgac278","volume":"107","author":"MT Korytkowski","year":"2022","unstructured":"Korytkowski\u00a0MT, Muniyappa\u00a0R, Antinori-Lent\u00a0K, et\u00a0al. Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline. JCEM Case Rep. 2022;107(8):2101\u201328. https:\/\/doi.org\/10.1210\/clinem\/dgac278.","journal-title":"J Clin Endocrinol Metab"},{"key":"2717_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2024.111627","volume":"99","author":"AD Oprea","year":"2024","unstructured":"Oprea\u00a0AD, Kalra\u00a0SK, Duggan\u00a0EW, et\u00a0al. Perioperative Management of Adult Patients with Diabetes Wearing Devices: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Expert Consensus Statement. J\u00a0Clin Anesth. 2024;99:111627. https:\/\/doi.org\/10.1016\/j.jclinane.2024.111627.","journal-title":"Journal of Clinical Anesthesia"},{"issue":"6","key":"2717_CR160","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1177\/1932296820930038","volume":"14","author":"AL Migdal","year":"2020","unstructured":"Migdal\u00a0AL, Spanakis\u00a0SE, Galindo\u00a0GR, et\u00a0al. Accuracy and Precision of Continuous Glucose Monitoring in Hospitalized Patients Undergoing Radiology Procedures. J\u00a0Diabetes Sci Technol. 2020;14(6):1135\u20136. https:\/\/doi.org\/10.1177\/1932296820930038.","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"2717_CR161","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1210\/jc.2010-2756","volume":"96","author":"DC Klonoff","year":"2011","unstructured":"Klonoff\u00a0DC, Buckingham\u00a0B, Christiansen\u00a0JS, et\u00a0al. Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J\u00a0Clin Endocrinol Metab. 2011;96(10):2968\u201379. https:\/\/doi.org\/10.1210\/jc.2010-2756.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2717_CR162","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/jhm.2109","volume":"8","author":"MC Lansang","year":"2013","unstructured":"Lansang\u00a0MC, Modic\u00a0MB, Sauvey\u00a0R, et\u00a0al. Approach to the adult hospitalized patient on an insulin pump. J\u00a0Hosp Med. 2013;8(12):721\u20137. https:\/\/doi.org\/10.1002\/jhm.2109.","journal-title":"J Hosp Med"},{"issue":"6","key":"2717_CR163","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1089\/dia.2020.0490","volume":"23","author":"SE Tellez","year":"2021","unstructured":"Tellez\u00a0SE, Hornung\u00a0LN, Courter\u00a0JD, et\u00a0al. Inaccurate Glucose Sensor Values After Hydroxyurea Administration. Diabetes Technol Ther. 2021;23(6):443\u201351. https:\/\/doi.org\/10.1089\/dia.2020.0490.","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"2717_CR164","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00134-024-07663-6","volume":"50","author":"CG Nielsen","year":"2024","unstructured":"Nielsen\u00a0CG, Grigonyte-Daraskeviciene\u00a0M, Olsen\u00a0MT, et\u00a0al. Accuracy of continuous glucose monitoring systems in intensive care unit patients: a scoping review. Intensive Care Med. 2024;50(12):2005\u201318. https:\/\/doi.org\/10.1007\/s00134-024-07663-6.","journal-title":"Intensive Care Med"},{"issue":"5","key":"2717_CR165","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jtcvs.2013.06.017","volume":"146","author":"SE Siegelaar","year":"2013","unstructured":"Siegelaar\u00a0SE, Barwari\u00a0T, Hermanides\u00a0J, van der Voort\u00a0PHJ, Hoekstra\u00a0JBL, DeVries\u00a0JH. Microcirculation and its relation to continuous subcutaneous glucose sensor accuracy in cardiac surgery patients in the intensive care unit. J\u00a0Thorac Cardiovasc Surg. 2013;146(5):1283\u20139. https:\/\/doi.org\/10.1016\/j.jtcvs.2013.06.017.","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"issue":"1","key":"2717_CR166","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/1932296816651632","volume":"11","author":"F Schierenbeck","year":"2016","unstructured":"Schierenbeck\u00a0F, Franco-Cereceda\u00a0A, Liska\u00a0J. Accuracy of 2 Different Continuous Glucose Monitoring Systems in Patients Undergoing Cardiac Surgery. J\u00a0Diabetes Sci Technol. 2016;11(1):108\u201316. https:\/\/doi.org\/10.1177\/1932296816651632.","journal-title":"J Diabetes Sci Technol"},{"key":"2717_CR167","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16462","author":"G Krutkyte","year":"2025","unstructured":"Krutkyte\u00a0G, Rolfes\u00a0ED, Herzig\u00a0D, et\u00a0al. Performance of the DEXCOM G7 CGM system during and after major surgery. Diabetes, Obesity and Metabolism. 2025; https:\/\/doi.org\/10.1111\/dom.16462.","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"2717_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111986","author":"GCL Chagas","year":"2025","unstructured":"Chagas\u00a0GCL, Teixeira\u00a0L, Clemente\u00a0MRC, et\u00a0al. Use of continuous glucose monitoring and point-of-care glucose testing in hospitalized patients with diabetes mellitus in non-intensive care unit settings: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract Suppl. 2025; https:\/\/doi.org\/10.1016\/j.diabres.2024.111986.","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"11","key":"2717_CR169","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.2337\/dci21-0043","volume":"44","author":"RIG Holt","year":"2021","unstructured":"Holt\u00a0RIG, DeVries\u00a0JH, Hess-Fischl\u00a0A, et\u00a0al. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44(11):2589\u2013625. https:\/\/doi.org\/10.2337\/dci21-0043.","journal-title":"Diabetes Care"},{"key":"2717_CR170","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005246","author":"CJ Carlsson","year":"2022","unstructured":"Carlsson\u00a0CJ, N\u00f8rgaard\u00a0K, Oxb\u00f8ll\u00a0AB, et\u00a0al. Continuous Glucose Monitoring Reveals Perioperative Hypoglycemia in Most Patients With Diabetes Undergoing Major Surgery: A Prospective Cohort Study. Annals of Surgery. 2022; https:\/\/doi.org\/10.1097\/SLA.0000000000005246.","journal-title":"Annals of Surgery"},{"issue":"11","key":"2717_CR171","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.2337\/dc20-0670","volume":"43","author":"BG Nair","year":"2020","unstructured":"Nair\u00a0BG, Dellinger\u00a0EP, Flum\u00a0DR, Rooke\u00a0GA, Hirsch\u00a0IB. A Pilot Study of the Feasibility and Accuracy of Inpatient Continuous Glucose Monitoring. Diabetes Care. 2020;43(11):e168\u2013e9. https:\/\/doi.org\/10.2337\/dc20-0670.","journal-title":"Diabetes Care"},{"issue":"11","key":"2717_CR172","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.2337\/dc19-2073","volume":"43","author":"RJ Galindo","year":"2020","unstructured":"Galindo\u00a0RJ, Migdal\u00a0AL, Davis\u00a0GM, et\u00a0al. Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen. Diabetes Care. 2020;43(11):2730\u20135. https:\/\/doi.org\/10.2337\/dc19-2073.","journal-title":"Diabetes Care"},{"issue":"11","key":"2717_CR173","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.2337\/dc20-1016","volume":"43","author":"AL Fortmann","year":"2020","unstructured":"Fortmann\u00a0AL, Spierling Bagsic\u00a0SR, Talavera\u00a0L, et\u00a0al. Glucose as the Fifth Vital Sign: A Randomized Controlled Trial of Continuous Glucose Monitoring in a Non-ICU Hospital Setting. Diabetes Care. 2020;43(11):2873\u20137. https:\/\/doi.org\/10.2337\/dc20-1016.","journal-title":"Diabetes Care"},{"key":"2717_CR174","doi-asserted-by":"publisher","unstructured":"Hochfellner D, Poettler T, Schoerghuber M, et\u00a0al. (2025) Accuracy and Safety of a\u00a0Novel Intravenous Continuous Glucose Monitoring System in Patients Admitted to a\u00a0Cardiothoracic ICU: A\u00a0Pilot Trial. J\u00a0Diabetes Sci Technol 19322968251342598. https:\/\/doi.org\/10.1177\/19322968251342598","DOI":"10.1177\/19322968251342598"},{"issue":"6","key":"2717_CR175","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1056\/NEJMoa1805233","volume":"379","author":"L Bally","year":"2018","unstructured":"Bally\u00a0L, Thabit\u00a0H, Hartnell\u00a0S, et\u00a0al. Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care. N Engl J Med. 2018;379(6):547\u201356. https:\/\/doi.org\/10.1056\/NEJMoa1805233.","journal-title":"N Engl J Med"},{"issue":"2","key":"2717_CR176","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S2213-8587(16)30280-7","volume":"5","author":"H Thabit","year":"2017","unstructured":"Thabit\u00a0H, Hartnell\u00a0S, Allen\u00a0JM, et\u00a0al. Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial. Lancet Diabetes Endocrinol. 2017;5(2):117\u201324. https:\/\/doi.org\/10.1016\/S2213-8587(16)30280-7.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2717_CR177","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.aace.2020.12.013","volume":"7","author":"Z Atif","year":"2021","unstructured":"Atif\u00a0Z, Halstrom\u00a0A, Peragallo-Dittko\u00a0V, Klek\u00a0SP. Efficacy of Hybrid Closed-Loop Insulin Delivery System in a\u00a0Hospital Setting: A\u00a0Case Series. AACE Clin Case Rep. 2021;7(3):184\u20138. https:\/\/doi.org\/10.1016\/j.aace.2020.12.013.","journal-title":"AACE Clin Case Rep"},{"issue":"7","key":"2717_CR178","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1089\/dia.2018.0060","volume":"20","author":"ZA Stewart","year":"2018","unstructured":"Stewart\u00a0ZA, Yamamoto\u00a0JM, Wilinska\u00a0ME, et\u00a0al. Adaptability of Closed Loop During Labor, Delivery, and Postpartum: A Secondary Analysis of Data from Two Randomized Crossover Trials in Type 1 Diabetes Pregnancy. Diabetes Technol Ther. 2018;20(7):501\u20135. https:\/\/doi.org\/10.1089\/dia.2018.0060.","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"2717_CR179","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1177\/1932296820954163","volume":"14","author":"RJ Galindo","year":"2020","unstructured":"Galindo\u00a0RJ, Umpierrez\u00a0GE, Rushakoff\u00a0RJ, et\u00a0al. Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline. J\u00a0Diabetes Sci Technol. 2020;14(6):1035\u201364. https:\/\/doi.org\/10.1177\/1932296820954163.","journal-title":"J Diabetes Sci Technol"},{"issue":"11","key":"2717_CR180","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1210\/js.2018-00262","volume":"2","author":"AL Peters","year":"2018","unstructured":"Peters\u00a0AL, Ahmann\u00a0AJ, Hirsch\u00a0IB, Raymond\u00a0JK. Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines. J\u00a0Endocr Soc. 2018;2(11):1214\u201325. https:\/\/doi.org\/10.1210\/js.2018-00262.","journal-title":"J Endocr Soc"},{"issue":"Suppl 1","key":"2717_CR181","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.2337\/dc22-S007","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S97\u2013S112. https:\/\/doi.org\/10.2337\/dc22-S007.","journal-title":"Diabetes Care"},{"issue":"4","key":"2717_CR182","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1177\/1932296818769933","volume":"12","author":"B Thompson","year":"2018","unstructured":"Thompson\u00a0B, Korytkowski\u00a0M, Klonoff\u00a0DC, Cook\u00a0CB. Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital. J\u00a0Diabetes Sci Technol. 2018;12(4):880\u20139. https:\/\/doi.org\/10.1177\/1932296818769933.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"2717_CR183","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/193229681200600502","volume":"6","author":"CB Cook","year":"2012","unstructured":"Cook\u00a0CB, Beer\u00a0KA, Seifert\u00a0KM, Boyle\u00a0ME, Mackey\u00a0PA, Castro\u00a0JC. Transitioning insulin pump therapy from the outpatient to the inpatient setting: a\u00a0review of 6\u00a0years\u2019 experience with 253 cases. J\u00a0Diabetes Sci Technol. 2012;6(5):995\u20131002. https:\/\/doi.org\/10.1177\/193229681200600502.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"2717_CR184","doi-asserted-by":"publisher","first-page":"415","DOI":"10.4158\/EP09063.ORR","volume":"15","author":"ML Noschese","year":"2009","unstructured":"Noschese\u00a0ML, DiNardo\u00a0MM, Donihi\u00a0AC, et\u00a0al. Patient outcomes after implementation of a protocol for inpatient insulin pump therapy. Endocr Pract. 2009;15(5):415\u201324. https:\/\/doi.org\/10.4158\/EP09063.ORR.","journal-title":"Endocr Pract"},{"issue":"2","key":"2717_CR185","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcjd.2014.01.011","volume":"38","author":"RL Houlden","year":"2014","unstructured":"Houlden\u00a0RL, Moore\u00a0S. In-hospital management of adults using insulin pump therapy. Can J Diabetes. 2014;38(2):126\u201333. https:\/\/doi.org\/10.1016\/j.jcjd.2014.01.011.","journal-title":"Can J Diabetes"},{"issue":"5","key":"2717_CR186","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4158\/EP.16.5.746","volume":"16","author":"G Grunberger","year":"2010","unstructured":"Grunberger\u00a0G, Bailey\u00a0TS, Cohen\u00a0AJ, et\u00a0al. Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. Endocr Pract. 2010;16(5):746\u201362. https:\/\/doi.org\/10.4158\/EP.16.5.746.","journal-title":"Endocr Pract"},{"issue":"3","key":"2717_CR187","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/19322968221137335","volume":"17","author":"P Avari","year":"2023","unstructured":"Avari\u00a0P, Lumb\u00a0A, Flanagan\u00a0D, et\u00a0al. Insulin Pumps and Hybrid Close Loop Systems Within Hospital: A Scoping Review and Practical Guidance From the Joint British Diabetes Societies for Inpatient Care. J\u00a0Diabetes Sci Technol. 2023;17(3):625\u201334. https:\/\/doi.org\/10.1177\/19322968221137335.","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"2717_CR188","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00508-023-02177-5","volume":"135","author":"JK Mader","year":"2023","unstructured":"Mader\u00a0JK, Brix\u00a0JM, Aberer\u00a0F, et\u00a0al. Diabetesmanagement im Krankenhaus (Update 2023). Wien Klin Wochenschr. 2023;135(1):242\u201355. https:\/\/doi.org\/10.1007\/s00508-023-02177-5.","journal-title":"Wien Klin Wochenschr"},{"issue":"8","key":"2717_CR189","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2337\/dci18-0002","volume":"41","author":"GE Umpierrez","year":"2018","unstructured":"Umpierrez\u00a0GE, Klonoff\u00a0DC. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care. 2018;41(8):1579\u201389. https:\/\/doi.org\/10.2337\/dci18-0002.","journal-title":"Diabetes Care"},{"issue":"10","key":"2717_CR190","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11892-017-0919-7","volume":"17","author":"CE Mendez","year":"2017","unstructured":"Mendez\u00a0CE, Umpierrez\u00a0GE. Management of Type 1 Diabetes in the Hospital Setting. Curr Diab Rep. 2017;17(10):98\u201398. https:\/\/doi.org\/10.1007\/s11892-017-0919-7.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"2717_CR191","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4158\/EP11157.OR","volume":"18","author":"AA Nassar","year":"2012","unstructured":"Nassar\u00a0AA, Boyle\u00a0ME, Seifert\u00a0KM, et\u00a0al. Insulin Pump Therapy in Patients with Diabetes Undergoing Surgery. Endocrine Practice. 2012;18(1):49\u201355. https:\/\/doi.org\/10.4158\/EP11157.OR.","journal-title":"Endocrine Practice"},{"issue":"1","key":"2717_CR192","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/bja\/aev347","volume":"116","author":"H Partridge","year":"2016","unstructured":"Partridge\u00a0H, Perkins\u00a0B, Mathieu\u00a0S, Nicholls\u00a0A, Adeniji\u00a0K. Clinical recommendations in the management of the patient with type\u00a01 diabetes on insulin pump therapy in the perioperative period: a\u00a0primer for the anaesthetist. BJA: British Journal of Anaesthesia. 2016;116(1):18\u201326. https:\/\/doi.org\/10.1093\/bja\/aev347.","journal-title":"BJA: British Journal of Anaesthesia"},{"issue":"5","key":"2717_CR193","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006549","volume":"281","author":"G Krutkyte","year":"2025","unstructured":"Krutkyte\u00a0G, Goerg\u00a0AMC, Grob\u00a0CA, et\u00a0al. Perioperative Fully Closed-loop Versus Usual Care Glucose Management in Adults Undergoing Major Abdominal Surgery: A Two-centre Randomized Controlled Trial. Annals of Surgery. 2025;281(5)732. https:\/\/doi.org\/10.1097\/SLA.0000000000006549.","journal-title":"Annals of Surgery"},{"issue":"9","key":"2717_CR194","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.2337\/dc22-0438","volume":"45","author":"D Herzig","year":"2022","unstructured":"Herzig\u00a0D, Suhner\u00a0S, Roos\u00a0J, et\u00a0al. Perioperative Fully Closed-Loop Insulin Delivery in Patients Undergoing Elective Surgery: An Open-Label, Randomized Controlled Trial. Diabetes Care. 2022;45(9):2076\u201383. https:\/\/doi.org\/10.2337\/dc22-0438.","journal-title":"Diabetes Care"},{"key":"2717_CR195","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01453-z","author":"CK Boughton","year":"2021","unstructured":"Boughton\u00a0CK, Tripyla\u00a0A, Hartnell\u00a0S, et\u00a0al. Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial. Nat Med. 2021; https:\/\/doi.org\/10.1038\/s41591-021-01453-z.","journal-title":"Nat Med"},{"issue":"3","key":"2717_CR196","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15452","volume":"42","author":"P Avari","year":"2025","unstructured":"Avari\u00a0P, Choudhary\u00a0P, Lumb\u00a0A, et\u00a0al. Using technology to support diabetes care in hospital: Guidelines from the Joint British Diabetes Societies for Inpatient Care (JBDS-IP) group and Diabetes Technology Network (DTN) UK. Diabet Med. 2025;42(3)e15452. https:\/\/doi.org\/10.1111\/dme.15452.","journal-title":"Diabet Med"},{"issue":"7","key":"2717_CR197","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15078","volume":"40","author":"TP Griffin","year":"2023","unstructured":"Griffin\u00a0TP, Gallen\u00a0G, Hartnell\u00a0S, et\u00a0al. UK\u2019s Association of British Clinical Diabetologist\u2019s Diabetes Technology Network (ABCD-DTN): Best practice guide for hybrid closed-loop therapy. Diabet Med. 2023;40(7)e15078. https:\/\/doi.org\/10.1111\/dme.15078.","journal-title":"Diabet Med"},{"issue":"2","key":"2717_CR198","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/193229681300700217","volume":"7","author":"KM Neubauer","year":"2013","unstructured":"Neubauer\u00a0KM, Schaupp\u00a0L, Plank\u00a0J, et\u00a0al. Failure to control hyperglycemia in noncritically ill diabetes patients despite standard glycemic management in a hospital setting. J\u00a0Diabetes Sci Technol. 2013;7(2):402\u20139. https:\/\/doi.org\/10.1177\/193229681300700217.","journal-title":"J Diabetes Sci Technol"},{"issue":"9","key":"2717_CR199","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1111\/dom.14458","volume":"23","author":"DA Hochfellner","year":"2021","unstructured":"Hochfellner\u00a0DA, Rainer\u00a0R, Ziko\u00a0H, et\u00a0al. Efficient and safe glycaemic control with basal-bolus insulin therapy during fasting periods in hospitalized patients with type 2 diabetes using decision support technology: A post hoc analysis. Diabetes Obes Metab. 2021;23(9):2161\u20139. https:\/\/doi.org\/10.1111\/dom.14458.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2717_CR200","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1932296816676501","volume":"11","author":"S Spat","year":"2017","unstructured":"Spat\u00a0S, Donsa\u00a0K, Beck\u00a0P, et\u00a0al. A Mobile Computerized Decision Support System to Prevent Hypoglycemia in Hospitalized Patients With Type 2 Diabetes Mellitus. J\u00a0Diabetes Sci Technol. 2017;11(1):20\u20138. https:\/\/doi.org\/10.1177\/1932296816676501.","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"2717_CR201","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1089\/dia.2015.0027","volume":"17","author":"KM Neubauer","year":"2015","unstructured":"Neubauer\u00a0KM, Mader\u00a0JK, H\u00f6ll\u00a0B, et\u00a0al. Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different Wards. Diabetes Technol Ther. 2015;17(10):685\u201392. https:\/\/doi.org\/10.1089\/dia.2015.0027.","journal-title":"Diabetes Technol Ther"},{"key":"2717_CR202","doi-asserted-by":"crossref","unstructured":"Donsa K, Beck P, H\u00f6ll B, et\u00a0al. (2016) Impact of errors in paper-based and computerized diabetes management with decision support for hospitalized patients with type\u00a02 diabetes. A\u00a0post-hoc analysis of a\u00a0before and after study. Int J Med Inform 90:58\u201367. https:\/\/doi.org\/10.1016\/j.ijmedinf.2016.03.007","DOI":"10.1016\/j.ijmedinf.2016.03.007"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-026-02717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-026-02717-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-026-02717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:14:14Z","timestamp":1779315254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-026-02717-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":202,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2717"],"URL":"https:\/\/doi.org\/10.1007\/s00508-026-02717-9","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.K.\u00a0Mader gibt folgende Offenlegungen an: Advisory Boards von Abbott Diabetes Care, Becton-Dickinson, Biomea Fusion, Dexcom, Eli Lilly, Embecta, Insulet, Medtronic, myLife, Novo Nordisk A\/S, Pharmasens, Roche Diabetes Care, Sanofi-Aventis, Tandem und Viatris; Honorare f\u00fcr Vortragst\u00e4tigkeit: A.\u00a0Menarini Diagnostics, Abbott Diabetes Care, Dexcom, Eli Lilly, Medtrust, MSD, Novo Nordisk A\/S, Roche Diabetes Care, Sanofi, Sinocare, Viatris und Ypsomed. Gesellschafterin: decide Clinical Software GmbH und elyte Diagnostics. F.\u00a0Aberer gibt folgende Offenlegungen an: erhielt Vortragshonorare von Sanofi Aventis, Novo Nordisk, AMGEN und Eli Lilly und war Mitglied in Advisory Boards von Eli Lilly und Novo Nordisk. J.M.\u00a0Brix hat von folgenden Unternehmen Honorare f\u00fcr Vortr\u00e4ge, Beratert\u00e4tigkeit sowie Forschungsunterst\u00fctzung erhalten: Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Dexcom, Eli Lilly, Medtronic, Novo Nordisk. D.A.\u00a0Hochfellner gibt folgende Offenlegungen an: Reisehonorare von Eli Lilly, Novo Nordisk, Novartis, MSD, Sanofi, Vortragst\u00e4tigkeit Novo Nordisk und Sanofi. A.-T.\u00a0Kietaibl gibt folgende Offenlegungen an: Advisory Board: Roche Diabetes Care Austria, Vortragst\u00e4tigkeit: Sanofi-Aventis, Kongressunterst\u00fctzung: Novo Nordisk, Eli Lilly, Boehringer Ingelheim. B.\u00a0Ludvik gibt folgende Offenlegungen an: \u201eGrants, research support and honorary for Advisory Boards and speaker\u2019s bureau\u201c: Amgen, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Madrigal, Novo Nordisk, Sanofi. M.\u00a0Resl gibt folgende Offenlegungen an: Honorare f\u00fcr Vortr\u00e4ge und\/oder Beratert\u00e4tigkeit bzw. Fortbildungsunterst\u00fctzung: Boehringer Ingelheim, Dexcom, Abbott, Eli Lilly. L.\u00a0Stechemesser gibt folgende Offenlegungen an: Vortragst\u00e4tigkeit und Forschungszusammenarbeit: Abbott, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, CSL Vifor, Dexcom, Eli Lilly, Medtronic, Medtrust, Mylan, Novartis, Novo Nordisk, Roche Diabetes Care, Sanofi-Aventis. A.\u00a0Vonbank: In den letzten 12\u00a0Monaten erhielt ich von folgenden Seiten Fortbildungsunterst\u00fctzungen bzw. Honorare f\u00fcr Forschungst\u00e4tigkeit, Beratungst\u00e4tigkeit oder Vortr\u00e4ge: Eli Lilly, Boehringer Ingelheim, Amarin, Daiichi Sankyo, Novo Nordisk, Sanofi-Aventis, AstraZeneca, Amgen, Bayer, LKH Feldkirch. H.\u00a0Sourij gibt folgende Offenlegungen an: Advisory Boards von Amgen, Amarin, Boehringer Ingelheim, Bayer, Eli Lilly, Daiichi Sankyo, Novartis, Novo Nordisk, Sanofi; M. Clodi hat von folgenden Unternehmen Honorare f\u00fcr Vortr\u00e4ge und Beratert\u00e4tigkeit erhalten: Novo Nordisk, Elli Lilly, Boehringer Ingelheim, AstraZeneca,Novartis,Daiichi Sankyo, Amgen, W\u00f6rwag, Sanofi, Amarin, Roche, Bayer, Sobi. Honorare f\u00fcr Vortragst\u00e4tigkeit: Amgen, Amarin, Boehringer Ingelheim, Bayer, Eli Lilly, Daiichi Sankyo, Novartis, Novo Nordisk, Sanofi. B.\u00a0F\u00f6ger und C.\u00a0Ress-Winkel geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}